Infect Chemother.
2020 Dec;52(4):496-502. 10.3947/ic.2020.52.4.496.
Decision on Chemotherapy amidst COVID-19 Pandemic: A Review and a Practical Approach from Iran
- Affiliations
-
- 1Clinical Oncology Department, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- KMID: 2509881
- DOI: http://doi.org/10.3947/ic.2020.52.4.496
Abstract
- To provide a step-by-step approach to chemotherapy (CTx) in the novel coronavirus disease 2019 (COVID-19) era. The COVID-19 pandemic is the current global issue resulting in vast health implications. Amid the COVID-19 era, special attention must be paid to at-risk groups, including patients with cancer. To our knowledge, there is a paucity of data on the decision for CTx during the pandemic. We herein provide practical recommendations on the CTx of cancer patients over the pandemic based on our experience in an educational hospital. The decision on CTx should be considered to be individualized based on clinical findings. We hope that our experience provides a practical guide for clinical oncologists to deliver more effective cancer care over the COVID-19 pandemic.
